Showing results (181-190 of 228) with videos related to

Sort By:
Pageof 23
ACS Medicinal Chemistry Letters|October 22, 2021
Potent Anti-Inflammatory, Arylpyrazole-Based Glucocorticoid Receptor Agonists That Do Not Impair Insulin SecretionBrandon J Kennedy, Ashley M Lato, Alexander R Fisch, et al.
International Journal of Radiation Oncology, Biology, Physics|June 20, 2022
Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck CancerCarryn M Anderson, Christopher M Lee, Deborah Saunders, et al.
Journal of the American College of Cardiology|November 13, 2007
Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM ProgramAkshay S Desai, Karl Swedberg, John J V McMurray, et al.
Circulation. Cardiovascular Quality and Outcomes|August 1, 2013
Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF)Jonathan G Howlett, Justin A Ezekowitz, Mohua Podder, et al.
European Journal of Heart Failure|April 27, 2010
Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programmeSu Min Chang, Christopher B Granger, Peter A Johansson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 10, 2019
The Power of Resolution: Contextualized Understanding of Biological Responses to Liver Injury Chemicals Using High-throughput Transcriptomics and Benchmark Concentration ModelingSreenivasa C Ramaiahgari, Scott S Auerbach, Trey O Saddler, et al.
European Journal of Heart Failure|June 1, 2005
Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programmeEileen O'Meara, Eldrin Lewis, Chris Granger, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 11, 2019
Evaluating Sufficient Similarity of Botanical Dietary Supplements: Combining Chemical and In Vitro Biological DataKristen R Ryan, Madelyn C Huang, Stephen S Ferguson, et al.
Science (New York, N.Y.)|February 16, 2023
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptorsMaxemiliano V Vargas, Lee E Dunlap, Chunyang Dong, et al.
Oral Oncology|March 30, 2017
High-dose versus weekly cisplatin definitive chemoradiotherapy for HPV-related oropharyngeal squamous cell carcinoma of the head and neckCesar Augusto Perez, Xiaoyong Wu, Mark J Amsbaugh, et al.
Pageof 23